브이티
018290KOSDAQ70.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
VT operates diverse businesses including cosmetics, lamination, housing supply, and biotechnology. The cosmetics division grew by approximately 19.5% year-over-year, driven by global market expansion, particularly in North America and Russia/CIS. The lamination division strengthens competitiveness through high-value product development, while the biotechnology division advances Alzheimer's treatment technology and international patent applications. In 2025, the cosmetics segment accounted for 93.59% of total revenue.
Number of Employees
277people
Average Salary
47.4M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Higher than industry avg (caution)
3.3x industry avg (excellent)
Half of industry avg (excellent)
Avg ▲23.7% (2-year basis)
Avg ▲59.1% (2-year basis)
Avg ROE 35.0% (improving, 3yr)
Detailed News Sentiment
- Positive메가존클라우드, 한미약품에 제약 특화 AI 에이전트 심는다…업스테이.....
메가존클라우드의 AI 기술 도입으로 브이티 관련 제약 산업의 효율성 향상 기대.
- Positive브이티, 2분기 매출 1317억원…유럽·중동 성장에 자사주 150억 매...
VT Corp reports strong Q2 revenue growth driven by European and Middle Eastern markets, complemented by shareholder value enhancement through share buybacks.
- Positive브이티, 150억 규모 자사주 취득 결정
VT Corp announces significant shareholder buyback totaling 150억원, enhancing shareholder value.
Detailed Momentum
Near 52w low (7%, downtrend)
1m -9.06% (falling)
Volume decreasing
Detailed Disclosure
- Neutral주식등의대량보유상황보고서(일반)2026-08-28
- Positive주요사항보고서(자기주식취득결정)2026-08-13
- Neutral반기보고서 (2026.06)2026-08-13
- Neutral기업설명회(IR)개최2026-08-11
